利用泛化模式来预测前列腺癌的预后,并设计治疗反应
Xiaomin Zhang1, Ye Wang2, Yifan Chang1
1Department of Urology, Shanghai Changhai Hospital, 200433 Shanghai, China.
这项研究开发了一种新的与ubiquitination相关的预后指数 (URPI),用于预测前列腺腺癌 (PRAD) 的结果. URPI 改善了PRAD患者的生存估计,为临床应用提供了宝贵的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 乌比基化是一种关键的翻译后修饰,与癌症调节有关.
- 在前列腺腺癌 (PRAD) 中,与ubiquitination相关的基因 (URG) 的预后价值尚不清楚.
研究的目的:
- 探索URG在PRAD中的作用.
- 评估URG对患者预后的潜在影响.
- 开发一个PRAD患者存活率的预测模型.
主要方法:
- 来自公共数据库 (>800名患者) 的PRAD患者数据分析.
- 无监督的聚类来识别与无处不在相关的模式.
- 预后URG和与ubiquitination相关的预后指数 (URPI) 通过使用包括Lasso Cox回归在内的统计方法来确定.
主要成果:
- 确定了四个与ubiquitination相关的子群.
- 通过LASSO分析,六个关键的URG被区分出来.
- 建立了一个经过验证的URPI,证明了显著的生存分层能力.
- 将URPI与临床数据相结合,提高了PRAD生存预测的准确性.
结论:
- 为PRAD建立了一个新的和验证的URPI.
- URPI为改善PRAD患者的生存估计提供了一个有前途的工具.
- 该指数可以指导个性化治疗策略,并改善临床管理.
更多相关视频
10:26Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Abnormal Proliferation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
